DAVIDE CAMPARI-MILANO NV (CPR.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:CPR - NL0015435975 - Common Stock
5.75 EUR
-0.02 (-0.28%)
Taking everything into account, CPR scores 4 out of 10 in our fundamental rating. CPR was compared to 29 industry peers in the Beverages industry. Both the profitability and the financial health of CPR get a neutral evaluation. Nothing too spectacular is happening here. CPR is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
CPR had positive earnings in the past year.
In the past year CPR had a positive cash flow from operations.
CPR had positive earnings in each of the past 5 years.
CPR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
CPR has a worse Return On Assets (2.51%) than 65.52% of its industry peers.
With a Return On Equity value of 5.44%, CPR is not doing good in the industry: 68.97% of the companies in the same industry are doing better.
CPR has a Return On Invested Capital (7.03%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for CPR is in line with the industry average of 7.95%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.51% | ||
| ROE | 5.44% | ||
| ROIC | 7.03% |
ROA(3y)4.29%
ROA(5y)4.52%
ROE(3y)9.66%
ROE(5y)10.08%
ROIC(3y)7.66%
ROIC(5y)7.27%
1.3 Margins
CPR has a Profit Margin of 6.57%. This is comparable to the rest of the industry: CPR outperforms 41.38% of its industry peers.
In the last couple of years the Profit Margin of CPR has declined.
CPR's Operating Margin of 21.32% is fine compared to the rest of the industry. CPR outperforms 65.52% of its industry peers.
In the last couple of years the Operating Margin of CPR has remained more or less at the same level.
Looking at the Gross Margin, with a value of 57.55%, CPR is in the better half of the industry, outperforming 75.86% of the companies in the same industry.
CPR's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.32% | ||
| PM (TTM) | 6.57% | ||
| GM | 57.55% |
OM growth 3Y3.05%
OM growth 5Y-0.43%
PM growth 3Y-20.58%
PM growth 5Y-17.07%
GM growth 3Y-1.21%
GM growth 5Y-1.11%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CPR is creating some value.
CPR has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CPR has more shares outstanding
CPR has about the same debt/assets ratio as last year.
2.2 Solvency
CPR has an Altman-Z score of 2.56. This is not the best score and indicates that CPR is in the grey zone with still only limited risk for bankruptcy at the moment.
CPR's Altman-Z score of 2.56 is fine compared to the rest of the industry. CPR outperforms 75.86% of its industry peers.
CPR has a debt to FCF ratio of 8.49. This is a slightly negative value and a sign of low solvency as CPR would need 8.49 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 8.49, CPR is in line with its industry, outperforming 48.28% of the companies in the same industry.
CPR has a Debt/Equity ratio of 0.64. This is a neutral value indicating CPR is somewhat dependend on debt financing.
CPR's Debt to Equity ratio of 0.64 is fine compared to the rest of the industry. CPR outperforms 68.97% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.64 | ||
| Debt/FCF | 8.49 | ||
| Altman-Z | 2.56 |
ROIC/WACC1.06
WACC6.65%
2.3 Liquidity
A Current Ratio of 2.32 indicates that CPR has no problem at all paying its short term obligations.
CPR has a Current ratio of 2.32. This is amongst the best in the industry. CPR outperforms 86.21% of its industry peers.
CPR has a Quick Ratio of 2.32. This is a bad value and indicates that CPR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a decent Quick ratio value of 0.91, CPR is doing good in the industry, outperforming 79.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.32 | ||
| Quick Ratio | 0.91 |
3. Growth
3.1 Past
The earnings per share for CPR have decreased strongly by -40.50% in the last year.
The Earnings Per Share has been decreasing by -8.12% on average over the past years.
CPR shows a small growth in Revenue. In the last year, the Revenue has grown by 5.18%.
CPR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.75% yearly.
EPS 1Y (TTM)-40.5%
EPS 3Y-11.44%
EPS 5Y-8.12%
EPS Q2Q%-8.36%
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.21%
Revenue growth 5Y10.75%
Sales Q2Q%0.3%
3.2 Future
The Earnings Per Share is expected to grow by 11.74% on average over the next years. This is quite good.
The Revenue is expected to grow by 4.51% on average over the next years.
EPS Next Y2.03%
EPS Next 2Y4.61%
EPS Next 3Y7.09%
EPS Next 5Y11.74%
Revenue Next Year1.47%
Revenue Next 2Y1.85%
Revenue Next 3Y2.98%
Revenue Next 5Y4.51%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
CPR is valuated quite expensively with a Price/Earnings ratio of 33.82.
Based on the Price/Earnings ratio, CPR is valued a bit more expensive than 79.31% of the companies in the same industry.
CPR is valuated rather expensively when we compare the Price/Earnings ratio to 26.26, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 17.70, the valuation of CPR can be described as rather expensive.
62.07% of the companies in the same industry are cheaper than CPR, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of CPR to the average of the S&P500 Index (23.68), we can say CPR is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.82 | ||
| Fwd PE | 17.7 |
4.2 Price Multiples
CPR's Enterprise Value to EBITDA is on the same level as the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as CPR.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.06 | ||
| EV/EBITDA | 11.68 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)16.68
PEG (5Y)N/A
EPS Next 2Y4.61%
EPS Next 3Y7.09%
5. Dividend
5.1 Amount
CPR has a Yearly Dividend Yield of 1.10%.
CPR's Dividend Yield is slightly below the industry average, which is at 2.83.
With a Dividend Yield of 1.10, CPR pays less dividend than the S&P500 average, which is at 1.87.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.1% |
5.2 History
The dividend of CPR decreases each year by -2.80%.
Dividend Growth(5Y)-2.8%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
CPR pays out 38.69% of its income as dividend. This is a sustainable payout ratio.
DP38.69%
EPS Next 2Y4.61%
EPS Next 3Y7.09%
BIT:CPR (12/18/2025, 7:00:00 PM)
5.75
-0.02 (-0.28%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)
Earnings (Next)
Inst Owners22.77%
Inst Owner ChangeN/A
Ins Owners51%
Ins Owner ChangeN/A
Market Cap7.08B
Revenue(TTM)3.07B
Net Income(TTM)201.60M
Analysts71.54
Price Target7.02 (22.09%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.1% |
Yearly Dividend0.04
Dividend Growth(5Y)-2.8%
DP38.69%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.93%
PT rev (3m)0.36%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.21%
EPS NY rev (3m)2.62%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.23%
Revenue NY rev (3m)-1.02%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.82 | ||
| Fwd PE | 17.7 | ||
| P/S | 2.31 | ||
| P/FCF | 22.06 | ||
| P/OCF | 10.86 | ||
| P/B | 1.91 | ||
| P/tB | 58.32 | ||
| EV/EBITDA | 11.68 |
EPS(TTM)0.17
EY2.96%
EPS(NY)0.32
Fwd EY5.65%
FCF(TTM)0.26
FCFY4.53%
OCF(TTM)0.53
OCFY9.21%
SpS2.49
BVpS3.01
TBVpS0.1
PEG (NY)16.68
PEG (5Y)N/A
Graham Number3.39
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.51% | ||
| ROE | 5.44% | ||
| ROCE | 9.58% | ||
| ROIC | 7.03% | ||
| ROICexc | 7.57% | ||
| ROICexgc | 17.42% | ||
| OM | 21.32% | ||
| PM (TTM) | 6.57% | ||
| GM | 57.55% | ||
| FCFM | 10.45% |
ROA(3y)4.29%
ROA(5y)4.52%
ROE(3y)9.66%
ROE(5y)10.08%
ROIC(3y)7.66%
ROIC(5y)7.27%
ROICexc(3y)8.52%
ROICexc(5y)8.34%
ROICexgc(3y)23.37%
ROICexgc(5y)25.9%
ROCE(3y)10.45%
ROCE(5y)9.91%
ROICexgc growth 3Y-20.45%
ROICexgc growth 5Y-21.73%
ROICexc growth 3Y-7.67%
ROICexc growth 5Y-5.91%
OM growth 3Y3.05%
OM growth 5Y-0.43%
PM growth 3Y-20.58%
PM growth 5Y-17.07%
GM growth 3Y-1.21%
GM growth 5Y-1.11%
F-Score6
Asset Turnover0.38
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.64 | ||
| Debt/FCF | 8.49 | ||
| Debt/EBITDA | 2.97 | ||
| Cap/Depr | 230.39% | ||
| Cap/Sales | 10.79% | ||
| Interest Coverage | 6.41 | ||
| Cash Conversion | 81.69% | ||
| Profit Quality | 159.18% | ||
| Current Ratio | 2.32 | ||
| Quick Ratio | 0.91 | ||
| Altman-Z | 2.56 |
F-Score6
WACC6.65%
ROIC/WACC1.06
Cap/Depr(3y)346.34%
Cap/Depr(5y)266.11%
Cap/Sales(3y)12.99%
Cap/Sales(5y)10.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40.5%
EPS 3Y-11.44%
EPS 5Y-8.12%
EPS Q2Q%-8.36%
EPS Next Y2.03%
EPS Next 2Y4.61%
EPS Next 3Y7.09%
EPS Next 5Y11.74%
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.21%
Revenue growth 5Y10.75%
Sales Q2Q%0.3%
Revenue Next Year1.47%
Revenue Next 2Y1.85%
Revenue Next 3Y2.98%
Revenue Next 5Y4.51%
EBIT growth 1Y6.42%
EBIT growth 3Y15.63%
EBIT growth 5Y10.27%
EBIT Next Year25.83%
EBIT Next 3Y12.31%
EBIT Next 5Y10.56%
FCF growth 1Y290.11%
FCF growth 3Y-14.61%
FCF growth 5Y-4.94%
OCF growth 1Y205.34%
OCF growth 3Y11.5%
OCF growth 5Y13.06%
DAVIDE CAMPARI-MILANO NV / CPR.MI FAQ
Can you provide the ChartMill fundamental rating for DAVIDE CAMPARI-MILANO NV?
ChartMill assigns a fundamental rating of 4 / 10 to CPR.MI.
What is the valuation status of DAVIDE CAMPARI-MILANO NV (CPR.MI) stock?
ChartMill assigns a valuation rating of 1 / 10 to DAVIDE CAMPARI-MILANO NV (CPR.MI). This can be considered as Overvalued.
What is the profitability of CPR stock?
DAVIDE CAMPARI-MILANO NV (CPR.MI) has a profitability rating of 4 / 10.
What is the valuation of DAVIDE CAMPARI-MILANO NV based on its PE and PB ratios?
The Price/Earnings (PE) ratio for DAVIDE CAMPARI-MILANO NV (CPR.MI) is 33.82 and the Price/Book (PB) ratio is 1.91.
How sustainable is the dividend of DAVIDE CAMPARI-MILANO NV (CPR.MI) stock?
The dividend rating of DAVIDE CAMPARI-MILANO NV (CPR.MI) is 2 / 10 and the dividend payout ratio is 38.69%.